Dr. Jawairia Memon, MD

Dr. Memon practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Memon's NPI, 1598049348, was assigned on September 28, 2011. Dr. Memon holds New Mexico license MD2024-0330.

Dr. Memon's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Memon's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Memon is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Memon to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Memon practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Memon's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Memon's licenses on file in 3 states: New Mexico, Colorado and Mississippi.

CMS data shows 268 Medicare services from Dr. Memon across 12 procedure codes in 2024, for 251 Medicare patients. Medicare paid $25,535 for them.

CMS counts 251 Medicare patients who saw Dr. Memon in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Memon's median patient age at 69, with 58% women.

In 2024, Dr. Memon wrote 360 Medicare Part D claims for 203 patients. 74% of them were for generic drugs. CMS names the drug for 251 of them, across 6 drugs with 11 or more claims each, at $5,337 in total drug cost. In 2023, CMS named 87 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Memon for performance year 2024, reported as part of a group. Dr. Memon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Memon as offering telehealth. CMS counts 70 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Memon, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Memon, published from 2014 to 2020. Dr. Memon's most frequent co-authors are Robert Allen Avery, MD, Chinemerem John Okwara, MD and Swathi Paleti, MD.

CMS Open Payments shows 50 general payments to Dr. Memon from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $676.